Dextran Permeability Assay

Dextran size provides a way to distinguish how strongly a barrier restricts molecular passage. When tight junctions and cell-cell contacts remain intact, larger dextrans generally cross less readily than smaller ones. Comparing movement across different dextran sizes can therefore reveal whether a barrier maintains selective restriction or has become more permissive.

These structures limit passage between neighboring cells, which is the paracellular route. If the contacts remain intact, less dextran reaches the opposite side of the barrier. Changes that weaken barrier organization can increase movement across this route, making dextran transfer a useful readout for altered endothelial or epithelial integrity.

A time course shows how rapidly dextran accumulates on the side opposite the original addition point. Quantifying movement at successive time points helps distinguish gradual passage from faster barrier leakage and allows researchers to compare permeability under different biological conditions, treatments, or model systems rather than relying on a single observation.

A typical workflow places a cell layer or membrane between two compartments, adds fluorescently labeled dextran to one side, and measures its appearance on the opposite side over time. Researchers then compare the measured transfer among experimental conditions to determine whether barrier permeability changes relative to the model’s baseline behavior.

Fluorescent labeling makes dextran movement detectable when material reaches the opposite side of the barrier. The resulting signal is quantified over time as an indicator of transfer. Greater movement corresponds to increased apparent permeability, while restricted signal progression supports stronger barrier retention, provided comparisons use the same assay conditions.

The assay is useful when investigators need to evaluate endothelial or epithelial barrier function. It can monitor permeability changes caused by inflammation or chemical treatment and support comparisons among disease models, tissue-engineered barriers, and drug research systems. Its value lies in linking experimental conditions to measurable changes in molecular passage.

Results can indicate whether a biological barrier has preserved or altered its integrity and whether paracellular transport has become more or less permissive. In disease-model and tissue-engineering studies, these measurements help compare barrier performance, while in drug research they can reveal permeability changes associated with chemical exposure or treatment.